THE JAMES CROOKS MEMORIAL FELLOWSHIP IN CLINICAL PHARMACOLOGY & THERAPEUTICS Scottlsh Charlty Number: SC052561 Accounts for th• year to 31 Dec•mr 2024 Contents Report of the Trustee5 Report by Independent Examlner Accounts Notes to the Accounts Appendices of Investments T**xvFe.' 01382229111 Fa¥.. 01382202288
The James Crnoks Memorial Fellowship in Clinxal Pharnwcology & Therdpeutl(s Rewt rfthe Tn for the year to 31 December2024 ee N(es1 Prth)n hdj at tkndee Universty wth"n r i rpabY1 ain1 Pharrrklcc r¥< AS9nl 24.IL2022 Trustees are nominatso t%1r9 trteSd I1r apwntsytht ¢orflmd ty fomwl Deal ofAssumptkn. The trustees <leal appwtdy a5 regards indutti¢n Ind tra9 on any rth trustees 4v1nj. Thfjs Ipdudes awareress of trust's r•)nsilitIe$. the otsvemino dtsJrf aJmnitrdtNe Tedu$. and the htstory and phik)sophlol approath of the charfty. A new tru&ee vlll recd COF¥es d the SmiOLsyears aCcnts, rn1r ol recenl tstee Ietsr aTr1 a copy of the OSCR t¢okkt"GuldaKe good pra¢tr for Charty TrLt#eef, If apprwlate. Trrtor6 Law LLP, Wnitthall HCe. 33 yen StrKf< EOI 48J Estlyn Partrs, 177 Pthwel Stree( Gy4 G2 7eL ndentExamh athr, La LLP. TheV l31r xi i>euwn¥krt DPI 4Q8 Scothsh Chty No,, SC052561 e[clarS include al or any one or rnore of'.- lal The UnNEr9ty Dejartt ot rnacOIV and Clinical Pharma(Dlogy; (bl The PhartEl1 Industry." (E} Dcpirtsryts of Flbarntok¥Jy. ClinKd Phorn)acDk)9y ènd Therapeutics, In pwtrcular. but Th)t exchJs(¥ely. Sn rethn to the bennlafty ty the UnNprsty OF fnd¢e VPDn tho reCornwdacn of the Fdbwshp Trustee5 of a fellyshIp li nwe of the frj w5: By in¥itiThJ an a(knovleW expert in the fidd of FIkwrnC, aintsl Phamiaco¢yJy orTherapeubcsto spend a short pEritJ ol al kasl b¥eek iry the University DePtOr PhwfflKoby4yand a nKal [1[[na(0ky, during whith pErKxJ the fellow appointed 11 gi¥ a Jrn Cm)ks Lere aThJ a wies of s¢rninars ftsr stsff •nd PU#gradu•t¢ swdents:
The James Crooks Memorfal Fellowshlp In Cllnlcal Phamjacology & Therapeutics Reportof the for the yearto 31 December2024 <at) 9Jkwting a Y(j Te&th in C)nKal PharmoTh cf reL)ted fiebts kn thith the UnNer5rty for extended peri# of re5eath of up to vithn the DepartTrwrt cl Pharmacdr4y and Cknlcal Phamiacokgy; aTrJ Suppo. a member ofthe staff in FfiuMXo0TrelJted in urbJertJkiw a of fvrther traini in a Cwartsnent ainical Phar[ThY ther within o or within the pharmaceuLtal Inthjstry,. The day.to4ay admlnlstratth 6 carrd ¢xrt ty Thcrtons Law LLP, as &nts for the TnJsL The trustees amualty to conslder grant appllcath)r and to any other reknnt a9)ts ¢Ythe Trusvs aff& The trustees have Conne thetr pjky ol makJtvJ (knat to tt#xe ar#1 Ir&Ututb)r& as dlreded In the trust deed. flnantes of the tru5L xe 5althd that are in to rn4ate exrK)sure to those n5ks. The tW5tees corfjider varfaly.llty of In¥estrtRnt retun to (thte the thènvs mw f01 TNS ts mibgèted try retèSnin9 expert investment managers and n9 a dl¥ershJed Ire5t There are rn re5trfction5 In the Deal C the tnffjtee5' W to Inrt The p)Hcy Is, ILW ierni, to Jdrpt J methym rf5k Invèstsnent Straw, IndLkllThJ 4ulty Investrnts, to wC#ju a baknce of IrK(Kr ar captsl grth, The flnantkal as sèt F•Je5 5 4TrJ 6. The reserve5 ofthe Trust orfglnate from Drlnal afbj sub5eiwrt capltal te4ue5ts, trJether wTth the vernent In ts value of Investrnents, and accurnulated revenue. Tr trustee5 have adop a reserves that ensures the conUnulrvJ ab11Ity of the Tnjst to rneet ts objethw. The thl of Ie reserlts W at 31 cerni 2024 was £198,666.6112023 £197.19q.08}. Fvtur• Shttyy No charyes a presenty envlw in the tntsys as tyJVln&J atam.
The James Crooks Memorlal FelloTNshlp In Clknkal Pharnwokngy &Thernpeull¢> Independent Examinerfs Report to the tNstees of The James Crooks Memorial Fellowship In ainlcal Pharniacology & Therapeutlcs I report on Ihe a¢court% Of the drtY ftjr Ihe wiodeThJed 31 Dtxtthr 2024 whKh n xt outon 5 te 9. This rewrt is rnade to thetrtee5, as a toty, in Kc((tsnce wth the tems of erwmert. Ny %wrk has LEen undertaken to erKble to report ryry opinw set tyjt below for rK) (ts purp)se. To the extent Ferynthd I do n¢t cert ty •4ume resrlwsttllty to anytr Lthr thantht tru5W. a$ 4 t. for my 14wk or ts this reprt Rospectlve nsponsibllitla% of trusioes •nd examln The trustees a responsible for the preparatrm of the ac£ounts kn ac1•e terms of the Charltles and Trustee Investment Iscothnd) Act 2QOS and the tharbes Accounts (Smtkndl Wuhb"cr6 20C6 las amendadl. The trust CLder tlwt the au(k't reqUIrrent of Regu ILYI){al to Ic} of the 2CrfJ6Pats Wulatn5 O)e5 not atdy. 11 i5 ry re5ponsithlty to exarnine the acamjts as requir8J undaT sth 41tll (cl rf the kt afft1 to gate whether partscuL31 mattws he come to ry att¢rty)n. B•sls ¢1 Indwndont slatoffl fv exaTr¥non Is ¢x kn x¢tyd•n wlth re9Jl#bx 11 of the I( A¢mws ie9Jl•#ws. Indu¢es • re41ew of actnt¥ keo by the eharfty and a ccnp15c• d tl nts Jxe5ertt•Y th recc(d& It a19) Indudes cordderabon of any unusual ftems cYdsdosJres In the x¢ounts. arnl seekseXplanaticfr¢M tk trustees¢oncwnir any 9xh matters. Tr prOureS LtTrJertaken ts) r¥)t wvide &1 the ev¥Jertt thw. be requfj In an aLK1f(, ar consequentty I do t exwess an aK1r( Op1 on trrt ty tr Kcoun Indqxndlnt •x•mln•rfi •lJt•rn l. vthch glves rne Mnable causeto teknethrt In w rnattrl respect the wutrerrats.. to keep accoUnn9 records h accordancetpAlh stttson 4411) la) 2C#J5 N£t aThl IWuLItlDn 4 01 the 2006 kcounts Regulatin5, ar to ppare KCOu wNth the acaKniing cunFty wlth Re9ukk>n 8 of the 2CQ6 unts Re9Uon$ halt rot been nrt or: 2. tr) whkh. in my 0kIn, allenlkn slwkl bedrawm In order to enai a pyopu urbkn5tandlr4J rA accounts to t Partrier For and on tehalf ( Logg LLP ThE V15im 51[j 20 Greerrnwket Dundee DDI 4QB 23 Septembw 2025
The James Crooks Memorial Fellowship in Clinical Pharnwcokn &Therapeutics Recelpts and Payments Aec¢unt for the year ended 31 December 2024 2024 2023 Rec•lpts 3W.SI 2,798.36 115 6x34 108 730.93 Totsl recdpts 119 90.85 111529.29 PJyment• CharItae atht*s 471X>.IXI 2,310. 4,141.68 3,484.16 Cost orwerffj fur 9O7A7 rthase of Investrnwts 113,00&06 114,166.62 T¢tal 757.61 dt for the yew 3 266.76 8 431.49 I runds are unfe5tr1cted.
The Jame5 Crooks Memorlal Fdlowshlp In aknkal Pharma(x>kngy & Therapeutlcs statement rf Balances as at 31 Dec•nber2024 2024 2023 Cash on deposlt and on h•NI Owing bakin 6,579.08 Fun(ts trarre to Charlty 15,01057 Deftit for the year aos*ng bakn 3 31132 6 579.08 Unrestrict6J Funds 3 31132 6 579.08 As valued at 31.12.24 Ertlmated Ulbllltlos •s rt 31.12.24 Thornwns Lasy LLP, Idtnln15traUw fee5 Evetyn P¥rtnws, porfolio rnanwert feBS llldependt Examlner Fee 3,12ts.IXI 557.71 L12LOO 2,4)0.00 1,020.tr)
The James Crooks Memorlal Fellowshlp In Cllnlcal Pharnmcology & Therapeutks Sthedule I 2024 2023 Dfvhjends Jnd Intrrest. P¥AFFei¥ I 3M56JI 2,798.36 Sche(lule Z Charftsbl• A¢llvltk• DtrIOn$ m#dE in yur1£SLKJ to 4 iTh¥Aduals) Suwort c¢sis {ScheJJle 31 oooJ)o 4700.00 1310.( 2024 T•ll Thcrntons, th•"r fee for Trust adrnnislnt ¢wmioons, p0&5 erc. fcv the pemtsj to 31.12.24 (inc VAT) ¥700.00 700.00 4400.00 HeTrJerson LwJie- IndeFt examlnatkn of the 2023 kcounts ¥020.00 020.¢0 Rerwal Athsory RUrner•I - 3QO.¢J Custody Charge5 121.05 141.68 700.00 841.6• edu 3 Supp)rt c ChaYe 2023 Tcl)I Thomtons, their fee ft)r Tnst Jmlnlswats)n. rnmi55iws, etG forthe wiod to ICL 2,3IOD) 4,620.C 31.12.23 vAr) Renewal Adwwry Renun•11- I,orAo? I.CW.07 Custcth Char5e5 16&09 166.09 No Trustees reoNed any nerati (Y frcth Ihe Trtst luriNJ thi% ry lheethJ yew. The Tnst has no employ
The James Crooks Memorfal Fellov•shlp In Clinical Pharmacology & Therapeuti SCIlUIe 4 2024 2023 907.87 SCIdle S StJtern¢nt of Revenue bJlJnce M at 31.12.24 2024 2023 Income rttew In the 3M3.20 2,798.36 LlstdtArtlons pak1 to benefid*s SuppJrt costs [1000.00) 1700.00 (816.80) 3,484.16 {685.80) 801 a5 al 31.12.23 8a1ce as at 31.12.24 150160 685.80
The James Crooks Memorial Fellovtship in ainical PharnCol0gV & Therapeuti Notes to the Accounts and General Notes regardlng the Flnanclal Servlces and Markets Act 2000, Law Society Rules and related mattevs Basls of Prnparation The Accounts are prepared In accordance wlth the Charftles Accounts (Scotlandl RegUlaonS 2006 (as amended). Investments etc In these Accounts stocks and shares, gllts, debentures and warrants are valued at thelr Stock Market valye, If Ilsted on a registered Stock Exchange, or otherwise at either li) the latest available valuation known to us or li1} cost, at our discretbon. Unit Trusts are valued at their approximate bid price. fe Assurance politie5 are not valued. Reolised 9alns or losses are transferred to Capltal. Unrealised appreaatl¢n or depreciation In the value of Investments- as compared to thelr CGT base costs - Is dealt wlth under-AdJu5tment on revaluatlon/rebaslng". Contract Not•s In terms of our Law Socety Rules we a requlred to fornard coples ol all Contract Notes relatlng to the sèle or purchase of Investments to cllents. In the case ol Trusts we fulfil thls requlrtment by forwarding a copy to the first named Indepent1ent Trustee {i.e. a Trustee who 15 Flot a partnerlnominee cornpany of our flmi) based on the order of Trustees set out ort the fitst Pa9e of the Trust ACunts, unless otherwlse agreed. Stockbrnker Commlsslons As lbur$ement of stockbroker commlssions recelved on the purchase or sale of stocks and shares Ss admlnistratlvely expenslve and as the amounts Involved are normally falrfy mlnor, our pract* Is not to relmburse such COMMIlon$ to the Trust. but to take them Into account In the overall assessment of our fees. Any commlsslons recelved through Thorntons Investment Managers a retalne(1 in full unless otherw15e agreed. Investment Managers The Trustees approve the contlnued appolntment of the Investment Mafiagers as detalled In the General Inforrnotlon sectlon In these Accounts, and on the me bos15 as contalned In the Investment and nancIal Sèrvlces Terms of Buslness Agreement currently In force. hTomln¢eshlp.' The trustees approve the appolntment of the nominee company as detalled In the General Informafjon sectlon In these Accounts to contlnue to hold certain or all of the investrnents owned by the trustees, and that on the same basls as contalned In the Investment and Flnanclal serv15 Temis of Buslness Agreement currently In force. Independent Examln•r The trustees apprDve the contlftued Ippolntrnent of the Independent examlner as detalkd In the Report of the trustees In these Accounts. Golng conrn At the time of appron9 the flnandal statèments. the trustees have a rea9)nable expertatlon that the Trust has adequate resources to continue in operational existente lor the foreseeable future. Thus the trustees continue to adopt the golng concern basls of accouning In preparfng the finafioal statements.
aNlThera oun Dividends & lrtt¢rEst rKeryed in the period ended 31 Oecember Z014 05101n024 J P MORGAN GLoLGRoWfH • INCOME P OADGBPO.OS 1210112024 Fund Cash Rebare No¥embtr 23 1810112024 FIDELITYGLOUL DIWDENDW INC 3UOII2024 TB EVENLODE INVESTMENTFUNDS ICVCTB EVEf4LODE INCOME F OYIOV2024 Fund Cash Robat• Det¢mber 23 2310212024 IKTOPUS RENEWABIES INFKdSTrUCTUAE 2810212024 RATHBONE UNfTTRUST MANAGEMeNT LTD iITHBONE ETHICALBO 1310312024 Fund Cash Rebatejanuary 2024 2810312024 IFSL MARL8OROUGH NO 2 OEIC IFSL MAALKSROUGH MVLlItAP W0312024 VONTO8EL FUNOTWENTYFOVR SHORTTERM BOND 3110312024 BAIiLIE GIFFORDVK & FD$ ILYC 1510412024 Fund C•sh Rebate February 2014 1610412024 JPMORGAN GROWTH & INCOME ORD 5P 1810412024 FIOELITY IW FOSGLOBAL DIVIDEND FUND 2210412024 VK GOVT3.5% 22110115 30IL412024 TB EVENLODE INVESTMENT FUNDS ICVCTB EVENLODE INCI)ME F 171OS11024 FINseLJRY GROWTh & INCOMÉ TRUST OHD 25P 2010511024 FIDELrrYGLOBAL DMDENDINC 3110S12024 RATHBONE VNITTAUST MANAGEMENT LTDILAThBONE UHICAL80 1810612024 FIDELIIY GLO&4LOMOENDINC 28IW2024 VONT08EL FUNDTWENIYFOUR SHORTTERM B014D 0110712024 BAILLIE GIFFORO UK & 8AL FDS IThC 0310712024 IPMORGAN GAowfH & INCO•AE ORO 5P 1810712024 FIDELITY GLoeAL DMDÉND INC 3010712014 UK Govfo.125% 30101126 3110712024 UK Gowf3.25% 31101133 3110712024 ARTEMIS INV FUNDSCORPOAATE OONO 01111024 TB EVENLOOE INVESTMENT FUNDS ICVCT8EVE14LODE INCOME F CJICffjI2024 8NY MELLON GLO8AL FUIIDS US EQuy INCOME 1910812024 FIDELtTYGLOBAL DMDENO IPK C$112014 VKGOVT 3.75%07103127 1810912024 FIDgLtTY6LOBAL DIVIDENO INC 26109n024 JPMOFIGAN GLOML OPPS SU 3010912024 VONTO8EL FVNDIWENIYFOUR 5HORTTEPM 8QND 10912024 6AILLIE GIFFORO UK & 8AL FD5 KVC 0711012024 JPMOR&4N GROWTH & INCOME ORO 5P 1811012024 FIDELITY GLoeAL OMDEND INC 1211012024 UK Govf 3.5%2V10125 3111012024 TB EVENLODE INVESfMEpifFVP4D51CVCIB EVENLOOE INCOME F 3111012024 ARTEMIS INV FUNDS CORPORATE bOND 11112024 BNY MELLON GLOOAL FUNDS USEQIJIIY INCOME CI11112024 FIN58URYGRowfH & INCOME TRUSTORD25P 18IIu2024 FIDELITYGLO8AL OIWDEND INC 1811212024 FIDELITYGLOBAL DIWDENO INC 3V12no24 VONTOBEL FufiDIWENTYFOUR 5HORTTERM 8OND 3111212024 BAILUE GIFFORD UK & UL FOS ICVC iU.66 0.36 0.38 1.12 138.63 154.84 180.96 93.•) 125.67 127.26 IS7.45 iyJ.>J 27.83 143.96 2Y.83 76.27 75.76 115.67 27.83 153.76 47.47 .49 20.63 27.83 122.51 27.83 o.oi 82.26 74.86 S.38 27.83 157.45 10.49 98.12 41.% 109.40 27.83 17.83 87.49 74.06 Int?rest fecemdforthewtsjto JI Ewh•2024 S7.66 3.866.51
TheJarn¢s Crooks Memorfal Fellowshl alnfjcal Pham dlx Accounts for the ried ended 31 Oecembef 2024 Investment sales and purthase5 forthe period ended 31 Oecernber 2024 Units In¥estment Sales 0510412024 12.422 ocropus RENEWA8LES INFRA TR PLCORD GBPO.01 0810412024 13.330.07 RATHBONE UNITTRUST MANAGEMENT LTD RATHBONE FfHICAL 8OND I DIS 0810412024 6,193.724 IFSL MARLBOROUGH MULn CAP INCOME P DIS 0810412024 81.222 VONTOBEL TWENIYFOUR SHORTTERM BONO 0810412024 149.41 JPMORGAN GLOBAL BD OPPS 3010712024 451 XTRACKERS PHYSICALGOID 30A)712024 354 FIN58URY GRowfH & INCOME ORD 25P 3110712024 2,163.3 INVESCO EUAOPEAN INV EUROPEAN EQUITY UK Z 3110712024 5,365.659 HEftiof INV FUNOS GLOBAL AACC 8.803.12 11,371.88 8.254.38 7.607.25 13.923.52 5.581.35 2.993.21 10.707.25 16.847.63 IFI 3110712024 38.6538 TM FULCRUM DIVERSIFIED ABST REfuRN ACC 3110711024 119.82 TRIUM UCITS PLATFORM EMISSIONS IMPROVERSACC 3110712024 O ARTEM15 INV FUNDS CORP 8OND- t91154t10Th 0910812024 0 8NY MELLOP4 GLoeAL FOS LIS EQUtrY INC- equ1$0ft 0411112024 352 JPMORGAN GLOBAL GRowfH & INCOME ORD 5P 0511112024 2,515 FIDELITY GLOBAL DIVIDEND INC 0811112024 O BNY MELLON GL08AL FOS US EqUV IMC.equ411satlon 18112n024 1628 LIONTrUSTEUROPEAN DYNM ACC 5.827.45 15.219.$4 49.71 22.05 2.Ch)3.79 2.987.82 6.41 3.417.98 115,624.34 Purchases 0510412024 8.997 UK 3.5% 8DS 22iion5 0510412024 9.076 UK GO3.75% BOS 07103n7 0510412024 9.462 UK GO3.25% BOS 31101133 0510412024 9.680 UK Goyf 0.125% BDS 30101126 0810412024 7,612.CIJS ARTEMIS INV FUNDSCORP BOND 0810412024 4.160,475 &NY MELLON GL0&4L FDS US EQUY•Nc 3010712024 301 KfRACKERS PHYSICAL GOID 3010712024 135.341 L)ODGE & COX WORLDWIDE US STOCK 3010712024 263.84 GUINNESS JSSET MANAGEMENT GLOBAL EQUIIYINCOME Z 3110712024 4.923.869 LioMfRusf PARTNERS EUROpN DYNM ACC 31107120Z4 53.97 NATIX15 INTERNATIONAL GRowfH EQUITY 31107n024 69.94 TAIUM UCITS PLATFORM CLIMATE IMPAcfACC 31107D024 1.780.838 BNY MELLON GLOBAL FDS US EQUtrY INC 0110812024 66.5583 MONfL4KE UCITS MYGALE EVENT DRIVEN 1511012024 I,C84 ARTEMIS INV FUNDS COAP BOND 15Jion024 6 NATIXIS INTERNAMONAL GRowfH Eourry 1811212024 850 PREMIER MITON INVESTMENT FUNDS USOPPSACC 9.OX.88 9,Q43.87 8,993.74 8,998.69 6,967.27 6,960.06 8.506.20 &oyJ.oi 8.C*JO.05 6.500.00 9.1MX).04 6.999.60 3.lYJO.IXS 7.lY)O.00 LW4.07 1.060.68 3.972.90 113.DJ8.06
4 ¥ ¥
Z J 3 r.